Quinoline-resistance reversing agents for the malaria parasite Plasmodium falciparum.
about
Functional characterization of the Plasmodium falciparum chloroquine-resistance transporter (PfCRT) in transformed Dictyostelium discoideum vesiclesChloroquine transport via the malaria parasite's chloroquine resistance transporterMultiple drugs compete for transport via the Plasmodium falciparum chloroquine resistance transporter at distinct but interdependent sitesChlorpheniramine Analogues Reverse Chloroquine Resistance in Plasmodium falciparum by Inhibiting PfCRT.Expanding the Antimalarial Drug Arsenal-Now, But How?Ruthenium(II) arene complexes with chelating chloroquine analogue ligands: synthesis, characterization and in vitro antimalarial activity.Malaria biology and disease pathogenesis: insights for new treatments.A whole cell pathway screen reveals seven novel chemosensitizers to combat chloroquine resistant malaria.Differential drug efflux or accumulation does not explain variation in the chloroquine response of Plasmodium falciparum strains expressing the same isoform of mutant PfCRT.Contrasting ex vivo efficacies of "reversed chloroquine" compounds in chloroquine-resistant Plasmodium falciparum and P. vivax isolates.Reversed chloroquine molecules as a strategy to overcome resistance in malaria.Novel 4-aminoquinoline analogs highly active against the blood and sexual stages of Plasmodium in vivo and in vitroDesign, synthesis, and evaluation of 10-N-substituted acridones as novel chemosensitizers in Plasmodium falciparum.Chloroquine resistance-conferring mutations in pfcrt give rise to a chloroquine-associated H+ leak from the malaria parasite's digestive vacuole.Synthesis, characterization, and in vitro antimalarial and antitumor activity of new ruthenium(II) complexes of chloroquine.Antimalarial drugs: modes of action and mechanisms of parasite resistance.Next-Generation Antimalarial Drugs: Hybrid Molecules as a New Strategy in Drug Design.Acridine and acridinones: old and new structures with antimalarial activity.Know your enemy: understanding the role of PfCRT in drug resistance could lead to new antimalarial tactics.Dual-functioning antimalarials that inhibit the chloroquine-resistance transporter.The mechanism of antimalarial action of the ruthenium(II)-chloroquine complex [RuCl(2)(CQ)] (2).Are Antimalarial Hybrid Molecules a Close Reality or a Distant Dream?The mechanism of antimalarial action of [Au(CQ)(PPh(3))]PF(6): structural effects and increased drug lipophilicity enhance heme aggregation inhibition at lipid/water interfaces.Pentamethylcyclopentadienyl-rhodium and iridium complexes containing (N^N and N^O) bound chloroquine analogue ligands: synthesis, characterization and antimalarial properties.The antimalarial activity of Ru-chloroquine complexes against resistant Plasmodium falciparum is related to lipophilicity, basicity, and heme aggregation inhibition ability near water/n-octanol interfaces.Chloroquine has not disappeared.Prevalence of chloroquine resistance alleles among Plasmodium falciparum parasites in countries affected by malaria disease since change of treatment policy: a systematic review protocol
P2860
Q28480526-B155E8AD-36E2-4AD8-893F-D647B0B2533AQ30041673-AD04BBAC-4131-46A0-BF28-5910C77393F3Q30041687-CA55904C-6128-47CD-8444-082586BB263FQ33636449-820AC731-08C7-41CF-8D13-86B3D705AB51Q33916111-1AC95DC2-328D-44B0-8EB6-061541323C4FQ34128946-866F4C9B-A6DF-43B2-B0BE-EF44960D9E5CQ34579700-D0BE3E3F-1C0A-4888-90E8-4D6EA5D70CB6Q34686526-9F9EB529-5CBA-4724-8844-E423FDAE5ED5Q34932500-5131B02E-269D-4455-A2D8-F98E3EE03BFFQ35684833-20905E43-CE19-4886-9381-FC7D2FF355C1Q35969822-09A7B3B8-4312-4D52-BD09-EAB3185347ABQ36172400-BD17D02B-988D-43B3-B00C-F117627B90FBQ36295369-DD1651F5-4139-480B-A37B-0BB6C39DDF91Q36993537-9DC39BC0-08C6-42E9-8F37-C8CE86B29C9EQ37169192-F2618D98-38DA-4103-896D-236F114D0DEFQ37820670-72D8272E-4FA1-4467-92B7-A9B5528EDDE9Q37852563-E00A0144-2A60-4CC5-B000-CD41948DD220Q37889659-DFB1CF7B-9F59-4DA1-ABB6-3AED1260D313Q37979631-8BA57364-8FDB-4AC1-950E-4BFC036B867DQ38093645-C3FBE9BE-4CCD-48C1-A0DB-B057E7678CAAQ38791312-EEA303FA-2390-4195-A263-297C1F173F0AQ39176524-E77FFBDD-FA68-49CF-860E-D9722069FB96Q41890103-97191882-C9D6-4980-A400-C6538488AA82Q41915835-CC011F4F-DF9E-4ECE-A2D1-6D4052704354Q41938737-0E33C55D-9917-42C5-907D-DCFBB915CEA2Q41941859-5E54DCA9-546E-460B-B075-71FD2B9A4645Q56355784-527AF2B5-9F3D-4805-997F-A59290FCFD5A
P2860
Quinoline-resistance reversing agents for the malaria parasite Plasmodium falciparum.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Quinoline-resistance reversing agents for the malaria parasite Plasmodium falciparum.
@ast
Quinoline-resistance reversing agents for the malaria parasite Plasmodium falciparum.
@en
type
label
Quinoline-resistance reversing agents for the malaria parasite Plasmodium falciparum.
@ast
Quinoline-resistance reversing agents for the malaria parasite Plasmodium falciparum.
@en
prefLabel
Quinoline-resistance reversing agents for the malaria parasite Plasmodium falciparum.
@ast
Quinoline-resistance reversing agents for the malaria parasite Plasmodium falciparum.
@en
P1476
Quinoline-resistance reversing agents for the malaria parasite Plasmodium falciparum.
@en
P2093
Donelly A van Schalkwyk
Timothy J Egan
P304
P356
10.1016/J.DRUP.2006.09.002
P577
2006-08-01T00:00:00Z